"This analysis along with other recent data suggest P2Y12 inhibitor monotherapy is the preferred antiplatelet approach for secondary prevention and is better than aspirin."—Michael C. McDaniel, MD, ...

For adults who have survived a heart attack or stroke, taking aspirin regularly may reduce the risk of another cardiovascular event. But a new study suggests that less than half of these ...